Ȩ > ´ÚÅÍÇÏÆ®¼Ò½Ä

 
¾È³çÇϽʴϱî? ´ÚÅÍÇÏÆ®¿¡¼­ °øÁö»çÇ×À» ¾Ë·Áµå¸³´Ï´Ù.
 
2024. 04. 25.
 Á¦12Â÷ ±¹Á¦ÀÌÁ¾À̽ÄÇÐȸ
±Û¾´ÀÌ: °ü¸®ÀÚ  ³¯Â¥: 2013.11.14. 11:32:57   Á¶È¸: 4226
2013³â 11¿ù 10ÀÏ~13ÀϱîÁö ÀϺ» ¿À»çÄ«, ¿À»çÄ«±¹Á¦È¸ÀÇÀå¿¡¼­ Á¦12Â÷ ±¹Á¦ÀÌÁ¾À̽ÄÇÐȸ Çмú´ëȸ°¡ ¼ºÈ²¸® °³ÃֵǾú´Ù.
Âü°¡ÀÚµéÀº Àü¼¼°è¸¦ Æ÷ÇÔÇÏ¿© ¹Ì±¹, À¯·´, È£ÁÖ, ´ºÁú¶õµå, Áß±¹, ÀϺ», Çѱ¹µî¿¡¼­ ¾à 400 ¿©¸íÀÇ ÀÌÁ¾À̽Ŀ¬±¸ °ü·ÃÇÐÀÚµéÀÌ 4ÀÏ°£ 400 ¿©ÆíÀÇ ÀÌÁ¾À̽İü·Ã ¿¬±¸¹ßÇ¥¿Í Ư°­, ½ÉÆ÷Áö¿òµîÀ¸·Î ¿­¶í Çмú´ëȸ°¡ ÁøÇàµÇ¾ú´Ù.
Çѱ¹¿¡¼­µµ ¿©·¯´ëÇп¡¼­ ¸¹Àº ¿¬±¸ÁøÀÌ Âü¼®ÇÏ¿´À¸¸ç ÃÊû°­¿¬, ¿¬±¸¹ßÇ¥¸¦ ½ÃÇàÇÏ¿´´Ù. ƯÈ÷ ¼­¿ï´ëÇб³ ÀÇ°ú´ëÇÐ ¿¬±¸ÁøÀÌ Çѱ¹ ´ëÇ¥µéÀÇ ÁÖ·ù¸¦ ÀÌ·ç°í ÃÊû°­ÀÇ, ÁÂÀå, ½Ê¿©ÆíÀÇ ¿¬±¸°á°ú¸¦ ¹ßÇ¥ÇÏ¿´´Ù. ¼­¿ï´ëÇб³º´¿ø ÈäºÎ¿Ü°ú¿¡¼­µµ  Development of novel combined anticalcification protocol including immunologic modification for prolonged durability of cardiac xenograft in animal study¿Í In-vivo efficacy for treatment with decellularization, alpha-galactosidase, spacefiller, organic solvent and detoxifixation of GA-fixed cardiac xenograft using alpha-gal mouse implantation model À̶õ ¿¬Á¦¸¦ ¹ßÇ¥ÇÏ¿´´Ù. ±Ý³â¿¡´Â alpha-gal KO pig¿¡ genetic modification ÁøÇàÀÌ ´õ¿í ÇöÀúÇÏ°í, genetically induced disease(agenesis) model°³¹ß, chimerism ¹æ¹ýµµ ´«ºÎ½Ã°Ô ¹ßÀüµÇ¾ú´Ù. Çѱ¹µµ ÀÌ·¯ÇÑ ÀÌÁ¾À̽Ŀ¡¼­ À¯ÀüÀÚ Ã³¸® ±â¼úµéÀÌ »¡¸® Çâ»óµÇ±æ ±â¿øÇÑ´Ù.
LIST  MODIFY DELETE WRITE  





Àüü±Û ¸ñ·Ï 2024. 04. 25.  Àüü±Û: 211  ¹æ¹®¼ö: 1024085
134 ÇÑÁßÀϼҾƽÉÀåÇÐȸ °ü¸®ÀÚ2013.03.27.4894
133 Á¦6Â÷ World Congress; ¼Ò¾Æ½ÉÀå °ü¸®ÀÚ2013.02.25.4001
132 ¾Æ¼¼¾Æ ÈäºÎ½ÉÀåÇ÷°üÇÐȸ °ü¸®ÀÚ2012.11.19.3972
131 Áß±¹ ÇϾóºó¾Æµ¿º´¿ø ½ÉÀå¼ö¼ú °ü¸®ÀÚ2012.10.24.4080
130 Áß±¹ÇϾóºó ¾Æµ¿º´¿ø °ü¸®ÀÚ2012.06.21.4334
129  8Â÷ ¾Æ½Ã¾Æ¼Ò¾Æ¿¬±¸ÇÐȸ,12Â÷ ´ëÇѼҾƽÉÀåÇÐȸ °ü¸®ÀÚ2012.05.21.5008
128 2012 ¼øȯ±â°ü·ÃÇÐȸ Ãá°èÅëÇÕÇмú´ëȸ °ü¸®ÀÚ2012.04.23.4150
127 Á¦4Â÷ ¾Æ½Ã¾Æ-ÅÂÆò¾ç ¼Ò¾Æ½ÉÀåÇÐȸ Çмú´ëȸ °ü¸®ÀÚ2012.04.09.4200
126 Á¦20Â÷ ¾Æ½Ã¾Æ ½ÉÀåÇ÷°üÈäºÎ¿Ü°úÇÐȸ °ü¸®ÀÚ2012.03.13.4285
125 Áß±¹ÇϾóºó ¾Æµ¿º´¿ø ½ÉÀå¼ö¼ú °ü¸®ÀÚ2011.12.19.4320
RELOAD WRITE
[1] [2] [3] [4] [5] [6] [7] 8 [9] [10]  ¢º 22